SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001140361-24-024395
Filing Date
2024-05-03
Accepted
2024-05-03 21:31:46
Documents
1
Group Members
BAM PARTNERS TRUSTBROOKFIELD ASSET MANAGEMENT LTD.BROOKFIELD ASSET MANAGEMENT ULCBROOKFIELD CORPOAKTREE CAPITAL HOLDINGS, LLCOAKTREE FUND ADMINISTRATION, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G ef20028420_sc13g.htm SC 13G 222576
  Complete submission text file 0001140361-24-024395.txt   224463
Mailing Address 333 SOUTH GRAND AVENUE 28TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH GRAND AVENUE 28TH FLOOR LOS ANGELES CA 90071 (213) 830-6300
Oaktree Capital Group Holdings GP, LLC (Filed by) CIK: 0001403525 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Subject) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91517 | Film No.: 24915322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)